d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits

d'Oliveira & Associates releases new webpages and infographic On Pradaxa lawsuits.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) March 06, 2013

Manufactured by Boehringer Ingelheim, Pradaxa is an anticoagulant drug that is used to treat a variety of blood and heart conditions*. In October 2010, the Food and Drug Administration (FDA) approved Pradaxa for sale on the market*. As reported by the NY Times, Pradaxa was marketed as a superior drug choice to Warfarin, but medical studies suggest that Pradaxa may be more dangerous than Warfarin*. The NY Times article goes on to explain that excessive bleeding from Warfarin can treated with Vitamin K, but the anticoagulant drug Pradaxa has no such treatment to counteract excessive bleeding*. The FDA lists the Pradaxa side effects that may include nosebleeds, discolored urine and stool, unusual hemorrhaging, headaches, and swelling**. More serious medical conditions linked to Pradaxa may include heart attack, stroke, and even death**. The USA Today reports the FDA has received over 3,781 reports of unfavorable Pradaxa side effects, which include about alleged 2,400 hemorrhages, 291 cases of acute renal failure, 640 strokes, and 542 deaths***.

Sources:
*http://www.nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html?_r=0
**http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***usatoday30.usatoday.com/news/health/story/2012-08-19/pradaxa-blood-thinner-lawsuit/57134628/1

Pradaxa lawsuits have alleged the drug contained inadequate warnings, which did not fairly apprise patients of the serious health risks associated with the drug*. Pradaxa’s manufacturer, Boehringer Ingelheim, also faces wrongful death claims and on August 8, 2012, Pradaxa lawsuits were consolidated in the United States District Court for the Southern District of Illinois (MDL-2385)*. Over 150 cases with 165 plaintiffs have been included in this Pradaxa Multidistrict Litigation*. Recently, the judge overseeing this litigation issued an order requiring Boehringer Ingelheim to produce “Paper and Pradaxa-Specific Electronic Custodial files**.”

Sources:
*http://www.ilsd.uscourts.gov/mdl/mdl2385.aspx
**http://www.ilsd.uscourts.gov/Documents/mdl2385/cmo17.pdf

If you believe that you or one of your loved ones has been injured by Pradaxa, you may want to speak with a personal injury lawyer regarding a dangerous drug claim. A Pradaxa lawyer familiar with new developments in the investigation of the drug Pradaxa may be able to help you make important personal and legal decisions. d'Oliveira & Associates, P.C. is working with some of the leading Pradaxa lawyers and dangerous drug attorneys in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C at 1-800-992-6878 or fill out a contact form for a free legal consultation.


Contact